🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.

RecruitingNAAges 4 Years - 12 YearsAllAmsterdam UMC, location VUmc
NCT06640894 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Rationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities. Consequently, the development of these children may be hampered. Recently, functional power training (FPT) emerged as a potentially successful supplementary treatment method to improve participation in children with CP. It is understood that FPT is more effective than progressive resistance training in improving walking ability and endurance, and thereby better supports participation in ambulatory children with CP. Nevertheless, high-level scientific evidence underpinning the efficacy of FPT on these parameters in ambulant children with

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12. * Gross Motor Function Classification System (GMFCS) level I - III. * Parents and/or children have a treatment question related to participation of the child. Exclusion Criteria: * Participants that suffer from a progressive neurological disorder. * Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period. * Treatment with botulinum toxin in the twelve weeks prior to participation in the study. * Treatment with serial casting in the three weeks prior to participation in the study. * Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study. * Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study. * Children that have received MegaPower training in the last 4 months before participation in the study. * Children for whom walking is not their preferred method of locomotion (yet).
💊

What it tests

  • MegaPower training
  • Usual Care
📍

Where

10 sites
Treant Zorggroep
Emmen, Netherlands
Merem
Almere Stad, Netherlands
Adelante zorggroep
Valkenburg, Netherlands
Revant
Breda, Netherlands
Reade
Amsterdam, Netherlands
Heliomare
Heemskerk, Netherlands
Merem
Hilversum, Netherlands
Roessingh
Enschede, Netherlands

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy